Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Lands $336K SBIR Grant

NEW YORK (GenomeWeb News) – GeneGo has won a $336,000 grant from the National Institute of General Medical Sciences, which it plans to use to create new types of signatures for drug resistance, the company said today.

GeneGo will use the Phase I Small Business Innovation Research grant in a collaboration with the Van Andel Institute for Translational Medicine that will focus on using GeneGo’s database and algorithms to identify key proteins in signaling networks.

"What we propose here is the novel concept of using inferred activity of key signaling proteins for building predictive models," GeneGo’s COO Andrej Bugrim said in a statement.

"Our early results indicate that such models should be significantly more robust than currently available diagnostic applications which are based directly on gene or protein levels," Bugrim added.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.